Suitable for a wide range of skin types with no downtime
A 2025 safety pilot in 2 healthy adults receiving intravenous BPC-157 found no adverse events and rapid clearance PMID: 40131143
Why it's relevant to psoriasis: Directly inhibits NF-B activation (central to psoriatic inflammation) Reduces pro-inflammatory cytokine production Used in inflammatory bowel disease research (similar immune dysregulation) No melanin-related effects unlike full alpha-MSH Research context: KPV has shown efficacy in reducing gut inflammation in colitis models
BPC-157 is cleared from circulation in approximately 15 minutes, yet its tissue repair signals persist for weeks, suggesting a hit-and-run pharmacological mechanism
Elastin production effectively stops after puberty
Peptides are short chains of amino acids (the building blocks of proteins) that function as messengers in the body, regulating key processes such as metabolism, cell repair, hormone production, and inflammation control